|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, less allowance for doubtful accounts of $51.6 in 2024 and $44.7 in 2023 | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Assets held-for-sale | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property, plant and equipment, less accumulated depreciation of $665.9 in 2024 and $675.4 in 2023 | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, less accumulated amortization of $967.4 in 2024 and $925.8 in 2023 | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Bank overdrafts | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Deferred revenues | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Liabilities held-for-sale | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Long-term debt, net | ||||||||||||||||||||
| Long-term operating lease liabilities | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Long-term tax payable | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| EQUITY | ||||||||||||||||||||
| Preferred stock (par value $0.01 per share, 1.0 shares authorized), mandatory convertible preferred stock, Series A, none issued and outstanding in 2023 and 2022 | ||||||||||||||||||||
| Common stock (par value $0.01 per share, 120.0 shares authorized, 92.8 and 92.6 issued and outstanding in 2024 and 2023, respectively) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total Stericycle, Inc.’s Equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total Equity | ||||||||||||||||||||
| Total Liabilities and Equity | ||||||||||||||||||||
Loading...
